Droplet Microactuator Automation for Nucleic Acid Amplification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current PCR-based DNA amplification methods are labor-intensive, costly, and prone to cross-contamination, and existing immunoassay analyzers are expensive and operator-dependent, limiting their use in point-of-sample collection settings and requiring large sample volumes.

Innovation Solution

A droplet-based nucleic acid amplification system using a droplet microactuator with electronic control and temperature control means for thermal cycling, allowing for efficient amplification of nucleic acids in small volumes and integration of multiple tests on a single chip.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Extent of automation

If conventional PCR-based DNA amplification methods are used, then amplification can be achieved, but the process is labor-intensive and prone to cross-contamination

Engineering Contradiction:
Improveautomation of amplification processVSAvoidlabor intensity
Core Design Contradiction:
Extent of automationVSEase of operation

Solution Approach 1:

The system uses magnetic beads that automatically bind to target DNA sequences and facilitate amplification without manual intervention. The beads perform the function of both reagent delivery and product capture, eliminating the need for operator-dependent steps and reducing cross-contamination risk.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent replaces manual mechanical operations with an automated magnetic actuation system. Magnetic fields are used to manipulate beads and control fluid movement, substituting operator-dependent mechanical steps with field-based control that reduces labor intensity and improves automation.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Measurement precision

If conventional PCR methods are used, then DNA amplification can be performed, but reagent costs are high and sensitivity is limited

Engineering Contradiction:
Improvedetection sensitivityVSAvoidreagent consumption
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The system segments the amplification process into discrete steps performed on individually manipulated magnetic beads. Each bead serves as a separate reaction unit, allowing for precise control of reagent amounts and enabling detection of individual DNA molecules, thereby improving sensitivity while reducing overall reagent consumption.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent changes the physical state and magnetic properties of beads to enhance detection sensitivity. By using superparamagnetic beads with optimized magnetic susceptibility, the system can detect and manipulate individual beads containing target DNA, improving measurement precision while using minimal reagent volumes.

Inventive Principle:
Principle #35Parameter changes

3Ease of manufacture

If nucleic acid sequencing machines are used, then sequencing can be performed, but the cost is expensive and not cost-effective

Engineering Contradiction:
Improvecost-effectivenessVSAvoidsample volume requirement
Core Design Contradiction:
Ease of manufactureVSQuantity of substance

Solution Approach 1:

The system uses disposable magnetic beads as single-use reaction carriers that can be discarded after one amplification cycle. This eliminates the need for expensive reusable sequencing machine components and makes the process cost-effective for widespread genetic testing, while requiring only minimal sample volumes.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

4Extent of automation

If immunoassays are used, then antigen detection can be performed, but significant sample volumes are required and operator dependence is high

Engineering Contradiction:
Improveoperator independenceVSAvoidoperator dependence
Core Design Contradiction:
Extent of automationVSEase of operation

Solution Approach 1:

The patent replaces operator-dependent manual operations with magnetic field-based automation. Magnetic beads automatically perform binding, washing, and detection functions, eliminating the need for operator intervention and making the system suitable for point-of-sample collection testing with minimal training required.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system enables rapid, cost-effective, and automated nucleic acid amplification and sequencing, reducing reagent consumption and operator dependence, facilitating point-of-sample collection testing and simultaneous monitoring of various analytes.

Implementation Method 1

A droplet microactuator includes a substrate, a magnetic field source arranged over the substrate, and a controller configured to operate the droplet microactuator

Methodology Applied
Scientific EffectMagnetic field manipulation: Magnetic Field

Implementation Method 2

one or more temperature control means arranged in proximity with one or more of the electrodes for heating a region of the droplet microactuator such that a droplet can be transported into the region for heating

Methodology Applied
Scientific EffectThermal cycling: Heating

Data Source

PatentUS9139865B2Droplet-based nucleic acid amplification method and apparatus
Publication Date: 2015.09.22 ADVANCED LIQUID LOGIC INC
  • US9139865B2 patent drawing
  • US9139865B2 patent drawing
  • US9139865B2 patent drawing

AI summary

Aspects of embodiments of the invention relate to a simulator including a visual display capable of outputting to a user a display one or more effects of a command series selected and a system including a droplet microactuator electronically coupled to and controlled by a processor capable of executing instructions, the droplet microactuator including a substrate comprising electrodes for conducting droplet operations. Further aspects of embodiments of the invention relate to a droplet operations troubleshooting apparatus. Other aspects of embodiments of the invention relate to a computer implemented method of displaying simulated microactuator droplets.